13F Holdings
中文EN

MMSI MERIT MEDICAL SYSTEMS INC

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 856982 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY9.1%
TTM net income YoY35.2%
TTM EPS YoY36.9%
Revenue 3-yr CAGR9.5%
Net income 3-yr CAGR16.9%

Margins

Gross margin49.4%
Operating margin13.5%
Net margin9.9%
FCF margin12.6%
EBITDA margin21.3%

Returns

ROE9.8%
ROA5.8%
ROIC (approx.)8.5%
Asset turnover0.58x

Leverage & solvency

Liabilities / assets40.4%
Debt / equity0.42x
Current ratio4.52x
Interest coverage6.73x

Cash quality & payout

Operating cash flow / net income1.71x
Accruals ratio-4.1%
Payout ratio—
Capex / revenue4.4%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$1.52B$1.36B$1.26B$1.15B$1.07B
Cost of revenue$777.64M$713.18M$673.49M$631.88M$589.42M
Gross profit$738.27M$643.33M$583.87M$519.10M$485.33M
R&D expense$97.35M$87.47M$82.73M$75.51M$71.25M
SG&A expense$455.21M$399.73M$373.68M$342.52M$335.69M
Operating income$184.72M$155.69M$123.94M$87.56M$60.92M
Interest expense$26.46M$31.22M$15.51M$6.34M$5.26M
Pretax income$170.94M$149.99M$112.09M$82.63M$53.92M
Income tax$42.45M$29.64M$17.68M$8.11M$5.46M
Net income$128.49M$120.36M$94.41M$74.52M$48.45M
EBITDA$307.89M$258.40M$213.93M$169.37M$144.98M
EPS (basic)2.172.071.641.310.86
EPS (diluted)2.132.031.621.290.84
Weighted avg. shares (diluted)60.46M59.37M58.36M57.67M57.36M
Balance sheet
Cash & equivalents$446.40M$378.77M$587.04M$60.56M$67.75M
Receivables$203.71M$190.24M$177.88M$164.68M$152.30M
Inventory$333.70M$306.06M$303.87M$265.99M$221.92M
Current assets$1.04B$923.77M$1.11B$529.08M$482.21M
PP&E, net$428.40M$386.17M$383.52M$382.98M$371.66M
Goodwill$506.84M$463.51M$382.24M$359.82M$361.74M
Total assets$2.69B$2.42B$2.33B$1.66B$1.65B
Current liabilities$239.76M$216.40M$203.56M$220.65M$236.28M
Short-term debt———$11.25M$8.44M
Long-term debt$734.04M$729.55M$823.01M$186.76M$234.40M
Total debt$734.04M$729.55M$823.01M$198.01M$242.84M
Total liabilities$1.10B$1.04B$1.12B$519.57M$608.50M
Shareholders' equity$1.58B$1.38B$1.20B$1.14B$1.04B
Net debt$287.63M$350.78M$235.98M$137.45M$175.09M
Shares outstanding59.42M58.74M57.86M57.31M56.57M
Cash flow statement
Operating cash flow$297.37M$220.80M$145.15M$114.29M$147.23M
Capital expenditure$81.72M$35.14M$34.29M$45.03M$27.94M
Free cash flow$215.66M$185.66M$110.86M$69.26M$119.29M
Investing cash flow-$247.39M-$368.65M-$175.35M-$57.40M-$37.16M
Financing cash flow$16.00M-$60.01M$559.27M-$60.26M-$98.44M
Depreciation & amortization$123.17M$102.71M$89.98M$81.80M$84.07M
Stock-based compensation$43.46M$28.47M$21.33M$18.04M$16.09M

Free plan shows the latest 5 periods; Pro shows all 17 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.